Multiple sclerosis trials in Finland

In Finland 9 Also abroad 506

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Where
Tampere
Age
18 years to 60 years
People
705 worldwide
Run by
Zenas BioPharma (USA), LLC
See details and how to joinNCT07067463 · EU 2025-524316-11-00
Phase 2Taking people
A Phase 2a Study of SUN-627 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Impact on Measures of Neuroinflammation in the Central Nervous System in Participants With Non-Active Progressive Multiple Sclerosis (SPMS/PPMS)
Where
Turku
Age
18 years and over
People
30
Run by
Sundance Biosciences Inc.
See details and how to join2026-525817-29-00 · EU 2026-525817-29-00
Phase 2Not yet taking people in Finland
TARGET-EBV in MS: Targeting Epstein Barr Virus with Tenofovir Alafenamide Fumarate in multiple sclerosis
Where
Turku
Age
18 years and over
People
61 worldwide
Run by
Oslo University Hospital HF
See details and how to join2025-522140-40-00 · EU 2025-522140-40-00
Phase 2Taking people
A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
Where
Turku
Age
18 years to 64 years
People
93 worldwide
Run by
Zenas Biopharma (USA) LLC
See details and how to join2024-512707-40-00 · EU 2024-512707-40-00
Phase 2Taking people
A clinical proof-of-concept study to reduce smoldering inflammation in progressive MS
Where
Turku
Age
18 years to 64 years
People
34
Run by
University Of Turku
See details and how to join2024-517336-21-00 · EU 2024-517336-21-00
Phase 3Taking people
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Where
Tampere
Age
18 years and over
People
677 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-521546-23-00 · EU 2025-521546-23-00
Phase 2Not yet taking people in Finland
Hydroxychloroquine in progressive MS
Where
Turku
Age
18 years and over
People
34
Run by
Varsinais-Suomen hyvinvointialue
See details and how to join2025-522573-11-00 · EU 2025-522573-11-00
No phaseEnrolling by invitation
Does Microglial Activation Promote Lesion Growth and Progression Among Multiple Sclerosis Patients
Where
Turku
Age
30 years to 80 years
People
100
Run by
Turku University Hospital
See details and how to joinNCT04625049
No phaseEnrolling by invitation
Exploring Pathology Related to Slowly Expanding Lesions Using Advanced Imaging
Where
Turku
Age
18 years to 80 years
People
15
Run by
Turku University Hospital
See details and how to joinNCT06460077